Effects of low and high plasma concentrations of dexmedetomidine on myocardial perfusion and cardiac function in healthy male subjects

Anesthesiology

Volumn 105, Issue 5, 2006, Pages 902-910

  Snapir, Amir ^a   Posti, Jussi ^a   Kentala, Erkki ^b   Koskenvuo, Juha ^b   Sundell, Jan ^b   Tuunanen, Helena ^b   Hakala, Kristo ^a   Scheinin, Harry ^b   Knuuti, Juhani ^b   Scheinin, Mika ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DEXMEDETOMIDINE; NORADRENALIN;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; ECHOCARDIOGRAPHY; HEART FUNCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE PERFUSION; HEMODYNAMICS; HUMAN; INFUSION RATE; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADRENERGIC ALPHA-AGONISTS; ADULT; BLOOD PRESSURE; CARDIAC OUTPUT; CORONARY CIRCULATION; DEXMEDETOMIDINE; ECHOCARDIOGRAPHY; EPINEPHRINE; HEART; HUMANS; INFUSIONS, INTRAVENOUS; MALE; NOREPINEPHRINE; POSITRON-EMISSION TOMOGRAPHY; VASCULAR RESISTANCE;

EID: 33750464516     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/00000542-200611000-00010     Document Type: Article

References (24)

1. 2- agonist-induced peripheral vasoconstriction in humans. ANESTHESIOLOGY 2003; 99:65-70
2. Figueroa XF, Poblete MI, Boric MP, Mendizabal VE, Adler-Graschinsky E, Huidobro-Toro JP: Clonidine-induced nitric oxide-dependent vasorelaxation mediated by endothelial alpha(2)-adrenoceptor activation. Br J Pharmacol 2001; 134:957-68
3. Link RE, Desai K, Hein L, Stevens ME, Chruscinski A, Bernstein D, Barsh GS, Kobilka BK: Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c. Science 1996; 273:803-5
4. Indolfi C, Piscione F, Villari B, Russolillo E, Rendina V, Golino P, Condorelli M, Chiariello M: Role of alpha 2-adrenoceptors in normal and atherosclerotic human coronary circulation. Circulation 1992; 86:1116-24
5. Baumgart D, Haude M, Gorge G, Liu F, Ge J, Grosse-Eggebrecht C, Erbel R, Heusch G: Augmented alpha-adrenergic constriction of atherosclerotic human coronary arteries. Circulation 1999; 99:2090-7
6. McCutcheon CA, Orme RM, Scott DA, Davies MJ, McGlade DP: A comparison of dexmedetomidine versus conventional therapy for sedation and hemodynamic control during carotid endarterectomy performed under regional anesthesia. Anesth Analg 2006; 102:668-75
7. Ramsay MA, Luterman DL: Dexmedetomidine as a total intravenous anesthetic agent. ANESTHESIOLOGY 2004; 101:787-90
8. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD: The effects of increasing plasma concentrations of dexmedetomidine in humans. ANESTHESIOLOGY 2000; 93:382-94
9. Small KM, Brown KM, Forbes SL, Liggett SB: Polymorphic deletion of three intracellular acidic residues of the alpha 2B-adrenergic receptor decreases G protein-coupled receptor kinase-mediated phosphorylation and desensitization. J Biol Chem 2001; 276:4917-22
10. Sundell J, Laine H, Luotolahti M, Nuutila P, Knuuti J: Increased coronary vascular resistance cannot be reduced by inhibiting sympathetic overactivity in hypertension. J Vasc Res 2002; 39:456-62
11. Iida H, Kanno I, Takahashi A, Miura S, Murakami M, Takahashi K, Ono Y, Shishido F, Inugami A, Tomura N: Measurement of absolute myocardial blood flow with H215O and dynamic positron-emission tomography: Strategy for quantification in relation to the partial-volume effect. Circulation 1988; 78:104-15
12. Iida H, Rhodes CG, de Silva R, Araujo LI, Bloomfield PM, Lammertsma AA, Jones T: Use of the left ventricular time-activity curve as a noninvasive input function in dynamic oxygen-15-water positron emission tomography. J Nucl Med 1992; 33:1669-77
13. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2:358-67
14. Ji QC, Zhou JY, Gonzales RJ, Gage EM, El Shourbagy TA: Simultaneous quantitation of dexmedetomidine and glucuronide metabolites (G-Dex-1 and G-Dex-2) in human plasma utilizing liquid chromatography with tandem mass spectrometric detection. Rapid Commun Mass Spectrom 2004; 18:1753-60
15. McCallum JB, Boban N, Hogan Q, Schmeling WT, Kampine JP, Bosnjak ZJ: The mechanism of alpha2-adrenergic inhibition of sympathetic ganglionic transmission. Anesth Analg 1998; 87:503-10
16. Thorin E, Huang PL, Fishman MC, Bevan JA: Nitric oxide inhibits alpha2-adrenoceptor-mediated endothelium-dependent vasodilation. Circ Res 1998; 82:1323-9
17. Gendron ME, Thorin E, Perrault LP: Loss of endothelial KATP channel-dependent, NO-mediated dilation of endocardial resistance coronary arteries in pigs with left ventricular hypertrophy. Br J Pharmacol 2004; 143:285-91
18. Cortigiani L, Desideri A, Bigi R: Noninvasive assessment of coronary artery disease: The role of stress echocardiography. Ital Heart J 2001; 2:250-5
19. Flacke WE, Flacke JW, Bloor BC, McIntee DF, Sagan M: Effects of dexmedetomidine on systemic and coronary hemodynamics in the anesthetized dog. J Cardiothorac Vasc Anesth 1993; 7:41-9
20. Jones CJ, DeFily DV, Patterson JL, Chilian WM: Endothelium-dependent relaxation competes with alpha 1- and alpha 2- adrenergic constriction in the canine epicardial coronary microcirculation. Circulation 1993; 87:1264-74
21. Brandes RP, Fleming I, Busse R: Endothelial aging. Cardiovasc Res 2005; 66:286-94
22. Lerman A, Zeiher AM: Endothelial function: cardiac events. Circulation 2005; 111:363-8
23. Petrofsky J, Lee S: The effects of type 2 diabetes and aging on vascular endothelial and autonomic function. Med Sci Monit 2005; 11:CR247-54
24. Flacke WE, Flacke JW, Blow KD, McIntee DF, Bloor BC: Effect of dexmedetomidine, an alpha 2-adrenergic agonist, in the isolated heart. J Cardiothorac Vasc Anesth 1992; 6:418-23